世界のHPV関連疾患市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global HPV Associated Disorder Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4327
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、HPV関連疾患の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（予防、治療）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・HPV関連疾患の市場動向
・企業の競争状況、市場シェア
・HPV関連疾患の種類別市場規模と予測2016-2027（予防、治療）
・HPV関連疾患の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局）
・HPV関連疾患の北米市場規模2016-2027（アメリカ、カナダ）
・HPV関連疾患の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・HPV関連疾患のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・HPV関連疾患の中南米市場規模2016-2027（メキシコ、ブラジル）
・HPV関連疾患の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Merck & Co., Inc、GlaxoSmithKline plc、F. Hoffmann-La Roche Ltd、Pfizer, Inc.、Allergan plc、AstraZeneca plc、Biocon Ltd、Eli Lilly and Company）
・結論

HPV Associated Disorder means a series of diseases associated with HPV, either pre-disease or some of the diseases induced thereby.

Market Analysis and Insights: Global HPV Associated Disorder Market
The global HPV Associated Disorder market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global HPV Associated Disorder market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global HPV Associated Disorder market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global HPV Associated Disorder market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global HPV Associated Disorder market.

Global HPV Associated Disorder Scope and Market Size
HPV Associated Disorder market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global HPV Associated Disorder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Prevention
Treatment

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck & Co., Inc
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd
Pfizer, Inc.
Allergan plc
AstraZeneca plc
Biocon Ltd
Eli Lilly and Company

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HPV Associated Disorder Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prevention
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global HPV Associated Disorder Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global HPV Associated Disorder Market Perspective (2016-2027)
2.2 HPV Associated Disorder Growth Trends by Regions
2.2.1 HPV Associated Disorder Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 HPV Associated Disorder Historic Market Share by Regions (2016-2021)
2.2.3 HPV Associated Disorder Forecasted Market Size by Regions (2022-2027)
2.3 HPV Associated Disorder Industry Dynamic
2.3.1 HPV Associated Disorder Market Trends
2.3.2 HPV Associated Disorder Market Drivers
2.3.3 HPV Associated Disorder Market Challenges
2.3.4 HPV Associated Disorder Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top HPV Associated Disorder Players by Revenue
3.1.1 Global Top HPV Associated Disorder Players by Revenue (2016-2021)
3.1.2 Global HPV Associated Disorder Revenue Market Share by Players (2016-2021)
3.2 Global HPV Associated Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by HPV Associated Disorder Revenue
3.4 Global HPV Associated Disorder Market Concentration Ratio
3.4.1 Global HPV Associated Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HPV Associated Disorder Revenue in 2020
3.5 HPV Associated Disorder Key Players Head office and Area Served
3.6 Key Players HPV Associated Disorder Product Solution and Service
3.7 Date of Enter into HPV Associated Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans

4 HPV Associated Disorder Breakdown Data by Type
4.1 Global HPV Associated Disorder Historic Market Size by Type (2016-2021)
4.2 Global HPV Associated Disorder Forecasted Market Size by Type (2022-2027)

5 HPV Associated Disorder Breakdown Data by Application
5.1 Global HPV Associated Disorder Historic Market Size by Application (2016-2021)
5.2 Global HPV Associated Disorder Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America HPV Associated Disorder Market Size (2016-2027)
6.2 North America HPV Associated Disorder Market Size by Type
6.2.1 North America HPV Associated Disorder Market Size by Type (2016-2021)
6.2.2 North America HPV Associated Disorder Market Size by Type (2022-2027)
6.2.3 North America HPV Associated Disorder Market Size by Type (2016-2027)
6.3 North America HPV Associated Disorder Market Size by Application
6.3.1 North America HPV Associated Disorder Market Size by Application (2016-2021)
6.3.2 North America HPV Associated Disorder Market Size by Application (2022-2027)
6.3.3 North America HPV Associated Disorder Market Size by Application (2016-2027)
6.4 North America HPV Associated Disorder Market Size by Country
6.4.1 North America HPV Associated Disorder Market Size by Country (2016-2021)
6.4.2 North America HPV Associated Disorder Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe HPV Associated Disorder Market Size (2016-2027)
7.2 Europe HPV Associated Disorder Market Size by Type
7.2.1 Europe HPV Associated Disorder Market Size by Type (2016-2021)
7.2.2 Europe HPV Associated Disorder Market Size by Type (2022-2027)
7.2.3 Europe HPV Associated Disorder Market Size by Type (2016-2027)
7.3 Europe HPV Associated Disorder Market Size by Application
7.3.1 Europe HPV Associated Disorder Market Size by Application (2016-2021)
7.3.2 Europe HPV Associated Disorder Market Size by Application (2022-2027)
7.3.3 Europe HPV Associated Disorder Market Size by Application (2016-2027)
7.4 Europe HPV Associated Disorder Market Size by Country
7.4.1 Europe HPV Associated Disorder Market Size by Country (2016-2021)
7.4.2 Europe HPV Associated Disorder Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific HPV Associated Disorder Market Size (2016-2027)
8.2 Asia-Pacific HPV Associated Disorder Market Size by Type
8.2.1 Asia-Pacific HPV Associated Disorder Market Size by Type (2016-2021)
8.2.2 Asia-Pacific HPV Associated Disorder Market Size by Type (2022-2027)
8.2.3 Asia-Pacific HPV Associated Disorder Market Size by Type (2016-2027)
8.3 Asia-Pacific HPV Associated Disorder Market Size by Application
8.3.1 Asia-Pacific HPV Associated Disorder Market Size by Application (2016-2021)
8.3.2 Asia-Pacific HPV Associated Disorder Market Size by Application (2022-2027)
8.3.3 Asia-Pacific HPV Associated Disorder Market Size by Application (2016-2027)
8.4 Asia-Pacific HPV Associated Disorder Market Size by Region
8.4.1 Asia-Pacific HPV Associated Disorder Market Size by Region (2016-2021)
8.4.2 Asia-Pacific HPV Associated Disorder Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America HPV Associated Disorder Market Size (2016-2027)
9.2 Latin America HPV Associated Disorder Market Size by Type
9.2.1 Latin America HPV Associated Disorder Market Size by Type (2016-2021)
9.2.2 Latin America HPV Associated Disorder Market Size by Type (2022-2027)
9.2.3 Latin America HPV Associated Disorder Market Size by Type (2016-2027)
9.3 Latin America HPV Associated Disorder Market Size by Application
9.3.1 Latin America HPV Associated Disorder Market Size by Application (2016-2021)
9.3.2 Latin America HPV Associated Disorder Market Size by Application (2022-2027)
9.3.3 Latin America HPV Associated Disorder Market Size by Application (2016-2027)
9.4 Latin America HPV Associated Disorder Market Size by Country
9.4.1 Latin America HPV Associated Disorder Market Size by Country (2016-2021)
9.4.2 Latin America HPV Associated Disorder Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa HPV Associated Disorder Market Size (2016-2027)
10.2 Middle East & Africa HPV Associated Disorder Market Size by Type
10.2.1 Middle East & Africa HPV Associated Disorder Market Size by Type (2016-2021)
10.2.2 Middle East & Africa HPV Associated Disorder Market Size by Type (2022-2027)
10.2.3 Middle East & Africa HPV Associated Disorder Market Size by Type (2016-2027)
10.3 Middle East & Africa HPV Associated Disorder Market Size by Application
10.3.1 Middle East & Africa HPV Associated Disorder Market Size by Application (2016-2021)
10.3.2 Middle East & Africa HPV Associated Disorder Market Size by Application (2022-2027)
10.3.3 Middle East & Africa HPV Associated Disorder Market Size by Application (2016-2027)
10.4 Middle East & Africa HPV Associated Disorder Market Size by Country
10.4.1 Middle East & Africa HPV Associated Disorder Market Size by Country (2016-2021)
10.4.2 Middle East & Africa HPV Associated Disorder Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck & Co., Inc
11.1.1 Merck & Co., Inc Company Details
11.1.2 Merck & Co., Inc Business Overview
11.1.3 Merck & Co., Inc HPV Associated Disorder Introduction
11.1.4 Merck & Co., Inc Revenue in HPV Associated Disorder Business (2016-2021)
11.1.5 Merck & Co., Inc Recent Development
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Details
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc HPV Associated Disorder Introduction
11.2.4 GlaxoSmithKline plc Revenue in HPV Associated Disorder Business (2016-2021)
11.2.5 GlaxoSmithKline plc Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd HPV Associated Disorder Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in HPV Associated Disorder Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Pfizer, Inc.
11.4.1 Pfizer, Inc. Company Details
11.4.2 Pfizer, Inc. Business Overview
11.4.3 Pfizer, Inc. HPV Associated Disorder Introduction
11.4.4 Pfizer, Inc. Revenue in HPV Associated Disorder Business (2016-2021)
11.4.5 Pfizer, Inc. Recent Development
11.5 Allergan plc
11.5.1 Allergan plc Company Details
11.5.2 Allergan plc Business Overview
11.5.3 Allergan plc HPV Associated Disorder Introduction
11.5.4 Allergan plc Revenue in HPV Associated Disorder Business (2016-2021)
11.5.5 Allergan plc Recent Development
11.6 AstraZeneca plc
11.6.1 AstraZeneca plc Company Details
11.6.2 AstraZeneca plc Business Overview
11.6.3 AstraZeneca plc HPV Associated Disorder Introduction
11.6.4 AstraZeneca plc Revenue in HPV Associated Disorder Business (2016-2021)
11.6.5 AstraZeneca plc Recent Development
11.7 Biocon Ltd
11.7.1 Biocon Ltd Company Details
11.7.2 Biocon Ltd Business Overview
11.7.3 Biocon Ltd HPV Associated Disorder Introduction
11.7.4 Biocon Ltd Revenue in HPV Associated Disorder Business (2016-2021)
11.7.5 Biocon Ltd Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company HPV Associated Disorder Introduction
11.8.4 Eli Lilly and Company Revenue in HPV Associated Disorder Business (2016-2021)
11.8.5 Eli Lilly and Company Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global HPV Associated Disorder Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prevention
Table 3. Key Players of Treatment
Table 4. Global HPV Associated Disorder Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global HPV Associated Disorder Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global HPV Associated Disorder Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global HPV Associated Disorder Market Share by Regions (2016-2021)
Table 8. Global HPV Associated Disorder Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global HPV Associated Disorder Market Share by Regions (2022-2027)
Table 10. HPV Associated Disorder Market Trends
Table 11. HPV Associated Disorder Market Drivers
Table 12. HPV Associated Disorder Market Challenges
Table 13. HPV Associated Disorder Market Restraints
Table 14. Global HPV Associated Disorder Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global HPV Associated Disorder Market Share by Players (2016-2021)
Table 16. Global Top HPV Associated Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HPV Associated Disorder as of 2020)
Table 17. Ranking of Global Top HPV Associated Disorder Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by HPV Associated Disorder Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players HPV Associated Disorder Product Solution and Service
Table 21. Date of Enter into HPV Associated Disorder Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global HPV Associated Disorder Market Size by Type (2016-2021) (US$ Million)
Table 24. Global HPV Associated Disorder Revenue Market Share by Type (2016-2021)
Table 25. Global HPV Associated Disorder Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global HPV Associated Disorder Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global HPV Associated Disorder Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global HPV Associated Disorder Revenue Market Share by Application (2016-2021)
Table 29. Global HPV Associated Disorder Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global HPV Associated Disorder Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America HPV Associated Disorder Market Size by Type (2016-2021) (US$ Million)
Table 32. North America HPV Associated Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America HPV Associated Disorder Market Size by Application (2016-2021) (US$ Million)
Table 34. North America HPV Associated Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America HPV Associated Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America HPV Associated Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe HPV Associated Disorder Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe HPV Associated Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe HPV Associated Disorder Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe HPV Associated Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe HPV Associated Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe HPV Associated Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific HPV Associated Disorder Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific HPV Associated Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific HPV Associated Disorder Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific HPV Associated Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific HPV Associated Disorder Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific HPV Associated Disorder Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America HPV Associated Disorder Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America HPV Associated Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America HPV Associated Disorder Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America HPV Associated Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America HPV Associated Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America HPV Associated Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa HPV Associated Disorder Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa HPV Associated Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa HPV Associated Disorder Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa HPV Associated Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa HPV Associated Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa HPV Associated Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck & Co., Inc Company Details
Table 62. Merck & Co., Inc Business Overview
Table 63. Merck & Co., Inc HPV Associated Disorder Product
Table 64. Merck & Co., Inc Revenue in HPV Associated Disorder Business (2016-2021) & (US$ Million)
Table 65. Merck & Co., Inc Recent Development
Table 66. GlaxoSmithKline plc Company Details
Table 67. GlaxoSmithKline plc Business Overview
Table 68. GlaxoSmithKline plc HPV Associated Disorder Product
Table 69. GlaxoSmithKline plc Revenue in HPV Associated Disorder Business (2016-2021) & (US$ Million)
Table 70. GlaxoSmithKline plc Recent Development
Table 71. F. Hoffmann-La Roche Ltd Company Details
Table 72. F. Hoffmann-La Roche Ltd Business Overview
Table 73. F. Hoffmann-La Roche Ltd HPV Associated Disorder Product
Table 74. F. Hoffmann-La Roche Ltd Revenue in HPV Associated Disorder Business (2016-2021) & (US$ Million)
Table 75. F. Hoffmann-La Roche Ltd Recent Development
Table 76. Pfizer, Inc. Company Details
Table 77. Pfizer, Inc. Business Overview
Table 78. Pfizer, Inc. HPV Associated Disorder Product
Table 79. Pfizer, Inc. Revenue in HPV Associated Disorder Business (2016-2021) & (US$ Million)
Table 80. Pfizer, Inc. Recent Development
Table 81. Allergan plc Company Details
Table 82. Allergan plc Business Overview
Table 83. Allergan plc HPV Associated Disorder Product
Table 84. Allergan plc Revenue in HPV Associated Disorder Business (2016-2021) & (US$ Million)
Table 85. Allergan plc Recent Development
Table 86. AstraZeneca plc Company Details
Table 87. AstraZeneca plc Business Overview
Table 88. AstraZeneca plc HPV Associated Disorder Product
Table 89. AstraZeneca plc Revenue in HPV Associated Disorder Business (2016-2021) & (US$ Million)
Table 90. AstraZeneca plc Recent Development
Table 91. Biocon Ltd Company Details
Table 92. Biocon Ltd Business Overview
Table 93. Biocon Ltd HPV Associated Disorder Product
Table 94. Biocon Ltd Revenue in HPV Associated Disorder Business (2016-2021) & (US$ Million)
Table 95. Biocon Ltd Recent Development
Table 96. Eli Lilly and Company Company Details
Table 97. Eli Lilly and Company Business Overview
Table 98. Eli Lilly and Company Revenue in HPV Associated Disorder Business (2016-2021) & (US$ Million)
Table 99. Eli Lilly and Company Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HPV Associated Disorder Market Share by Type: 2020 VS 2027
Figure 2. Prevention Features
Figure 3. Treatment Features
Figure 4. Global HPV Associated Disorder Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. HPV Associated Disorder Report Years Considered
Figure 9. Global HPV Associated Disorder Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global HPV Associated Disorder Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global HPV Associated Disorder Market Share by Regions: 2020 VS 2027
Figure 12. Global HPV Associated Disorder Market Share by Regions (2022-2027)
Figure 13. Global HPV Associated Disorder Market Share by Players in 2020
Figure 14. Global Top HPV Associated Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HPV Associated Disorder as of 2020
Figure 15. The Top 10 and 5 Players Market Share by HPV Associated Disorder Revenue in 2020
Figure 16. Global HPV Associated Disorder Revenue Market Share by Type (2016-2021)
Figure 17. Global HPV Associated Disorder Revenue Market Share by Type (2022-2027)
Figure 18. North America HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America HPV Associated Disorder Market Share by Type (2016-2027)
Figure 20. North America HPV Associated Disorder Market Share by Application (2016-2027)
Figure 21. North America HPV Associated Disorder Market Share by Country (2016-2027)
Figure 22. United States HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe HPV Associated Disorder Market Share by Type (2016-2027)
Figure 26. Europe HPV Associated Disorder Market Share by Application (2016-2027)
Figure 27. Europe HPV Associated Disorder Market Share by Country (2016-2027)
Figure 28. Germany HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific HPV Associated Disorder Market Share by Type (2016-2027)
Figure 36. Asia-Pacific HPV Associated Disorder Market Share by Application (2016-2027)
Figure 37. Asia-Pacific HPV Associated Disorder Market Share by Region (2016-2027)
Figure 38. China HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America HPV Associated Disorder Market Share by Type (2016-2027)
Figure 46. Latin America HPV Associated Disorder Market Share by Application (2016-2027)
Figure 47. Latin America HPV Associated Disorder Market Share by Country (2016-2027)
Figure 48. Mexico HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa HPV Associated Disorder Market Share by Type (2016-2027)
Figure 52. Middle East & Africa HPV Associated Disorder Market Share by Application (2016-2027)
Figure 53. Middle East & Africa HPV Associated Disorder Market Share by Country (2016-2027)
Figure 54. Turkey HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE HPV Associated Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Merck & Co., Inc Revenue Growth Rate in HPV Associated Disorder Business (2016-2021)
Figure 58. GlaxoSmithKline plc Revenue Growth Rate in HPV Associated Disorder Business (2016-2021)
Figure 59. F. Hoffmann-La Roche Ltd Revenue Growth Rate in HPV Associated Disorder Business (2016-2021)
Figure 60. Pfizer, Inc. Revenue Growth Rate in HPV Associated Disorder Business (2016-2021)
Figure 61. Allergan plc Revenue Growth Rate in HPV Associated Disorder Business (2016-2021)
Figure 62. AstraZeneca plc Revenue Growth Rate in HPV Associated Disorder Business (2016-2021)
Figure 63. Biocon Ltd Revenue Growth Rate in HPV Associated Disorder Business (2016-2021)
Figure 64. Eli Lilly and Company Revenue Growth Rate in HPV Associated Disorder Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界の甲状腺障害市場規模・現状・予測（2021年-2027年）

Global Thyroid Disorder Market Size, Status and Forecast 2021-2027
QFJ1-6041 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、甲状腺障害の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（甲状腺機能低下症、甲状腺機能亢進症）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のCDKL5欠乏症（CDD）市場規模・現状・予測（2021年-2027年）

Global CDKL5 Deficiency Disorder (CDD) Market Size, Status and Forecast 2021-2027
QFJ1-3983 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、CDKL5欠乏症（CDD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（従来型医薬品、新型医薬品）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の神経疾患診断市場規模・現状・予測（2021年-2027年）

Global Neurological Disorder Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4569 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、神経疾患診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イメージング技術、体外診断技術）、用途別市場規模（病院・クリニック、診断センター、外来診療センター）、主要地域別市場規模（北米、アメリカ、欧...

世界の強迫性障害治療薬市場規模・現状・予測（2021年-2027年）

Global Obsessive-Compulsive Disorder Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5903 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、強迫性障害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（SSRI、TCA、その他）、用途別市場規模（病院、クリニック、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のオピオイド使用障害市場規模・現状・予測（2021年-2027年）

Global Opioid Use Disorder Market Size, Status and Forecast 2021-2027
QFJ1-4617 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、オピオイド使用障害の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブプレノルフィン、メタドン、ナルトレキソン）、用途別市場規模（中等度疼痛治療、重度疼痛治療）、主要地域別市場規模（北米、アメリカ、欧州...

世界の物質使用障害治療市場規模・現状・予測（2021年-2027年）

Global Substance Use Disorder Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4914 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、物質使用障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルコール乱用治療、ニコチン乱用治療、薬物乱用治療）、用途別市場規模（病院、クリニック、在宅医療設備）、主要地域別市場規模（北米、アメリ...

世界の網膜障害治療市場規模・現状・予測（2021年-2027年）

Global Retinal Disorder Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4826 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、網膜障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ジェル、カプセル＆錠剤、点眼薬、軟膏）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の月経前不快気分障害（PMDD）市場規模・現状・予測（2021年-2027年）

Global Premenstrual Dysphoric Disorder (PMDD) Market Size, Status and Forecast 2021-2027
QFJ1-4754 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、月経前不快気分障害（PMDD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、注入剤、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の心的外傷後ストレス障害治療薬市場規模・現状・予測（2021年-2027年）

Global Post-Traumatic Stress Disorder Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4738 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、心的外傷後ストレス障害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗うつ薬、抗不安薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の排卵障害診断市場規模・現状・予測（2021年-2027年）

Global Ovulation Disorder Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-5286 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、排卵障害診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン検査、視床下部検出、卵巣生検、その他）、用途別市場規模（病院、婦人科クリニック）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界のピカ摂食障害治療市場規模・現状・予測（2021年-2027年） Pica is an eating disorder in which people eat nonnutritive substances which are not typically thought as food such as paper, cloth, soap, hair, wool, soil, chalk, string, talcum powder, gum, paint, metal, pebbles, charcoal, ash, clay, starch, or ice. This can lead to intoxication in children which …
HPV関連障害のグローバル市場：規模・現状・予測2019-2025 HPV Associated Disorder means a series of diseases associated with HPV, either pre-disease or some of the diseases induced thereby.In 2018, the global HPV Associated Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-…
HPV関連障害のグローバル市場：規模・現状・予測2019-2025 HPV Associated Disorder means a series of diseases associated with HPV, either pre-disease or some of the diseases induced thereby.In 2018, the global HPV Associated Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-…
HPV関連障害のグローバル市場：規模・現状・予測2019-2025 HPV Associated Disorder means a series of diseases associated with HPV, either pre-disease or some of the diseases induced thereby.In 2018, the global HPV Associated Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-…
世界の網膜障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Retinal Disorder Treatment Market The global Retinal Disorder Treatment market size is projected to reach US$ 10890 million by 2027, from US$ 7860.7 million in 2020, at a CAGR of 4.3% during 2021-2027. With industry-standard accuracy in analysis and high data int…